BRIDGEWATER, N.J. — Sanofi has launched ACT Kids Toothpaste, complementing the ACT brand’s lineup of oral rinses for children. Sanofi said ACT Kids Toothpaste is an anti-cavity fluoride toothpaste specially designed for children ages 2 and older. The toothpaste strengthens and protects developing teeth and helps prevent cavities. With ACT Kids Toothpaste’s Bubble Gum Blowout
BRIDGEWATER, N.J. — Sanofi is adding to its roster of prescription-to-OTC allergy medications with Xyzal Allergy 24HR. The Food and Drug Administration has approved Xyzal Allergy 24HR (levocetirizine dihydrochloride) as an over-the-counter treatment to alleviate symptoms of seasonal and year-round allergies, Sanofi said Wednesday. The product offers proven 24-hour relief from runny nose, sneezing, itchy
PARIS — Sanofi has agreed to a 22.8 billion euro ($25.1 billion) asset swap with Germany’s Boehringer Ingelheim GmbH that will boost the French drug manufacturer’s business in selling over-the-counter drugs. The two companies reached a definitive agreement late Monday after announcing exclusive negotiations in December. Terms are unchanged from the original announcement: Sanofi will